SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-074292
Filing Date
2023-06-23
Accepted
2023-06-23 16:30:59
Documents
1
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2319485-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2319485-2_4seq1.xml 4 6604
  Complete submission text file 0001104659-23-074292.txt   8115
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Bedrosian Camille L (Reporting) CIK: 0001326969 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38223 | Film No.: 231038179

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations